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Mitochondrial dysfunction has long been implicated in the
etiopathogenesis of Parkinson's disease (PD), based on the observa-
tion that mitochondrial toxins can cause parkinsonism in humans and
animal models. Research into the function and dysfunction of PD-
associated genes revealed that at least some of these genes interface
with pathways regulating various aspects of mitochondrial biology.
Mutations in the parkin gene, encoding an E3 ubiquitin ligase, are
responsible for the majority of autosomal recessive parkinsonism.
Our previous work revealed that parkin is a stress-inducible protein
with a wide neuroprotective capacity, preventing cell death under
various stress conditions. We now present evidence that the acute
stress-protective activity of parkin and its capacity to induce
mitophagy are mediated by two separate and independent pathways.
While a functional autophagic machinery and expression of the
mitochondrial kinase PINK1 is required for parkin-induced mitophagy,
these components are dispensable for the anti-apoptotic activity of
parkin. We identiﬁed a signaling pathway that is essential for the anti-
apoptotic activity of parkin but not for induction of mitophagy. In
support of this concept, parkin seems to exert adaptive effects on
mitochondria depending on the severity of mitochondrial damage.
Parkin prevents stress-induced cell death under moderate stress
conditions with only minor mitochondrial defects. However, when
mitochondria are irreversibly damaged in response to severe stress,
parkin can promote their elimination via mitophagy.
doi:10.1016/j.bbabio.2012.06.212
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Mutations in PTEN-induced putative kinase 1 (PINK1) cause a
recessive form of Parkinson's disease (PD). PINK1 is associated with
mitochondrial quality control and its partial knock-down induces
mitochondrial dysfunction including decreased membrane potential
and increased vulnerability against mitochondrial toxins, but the
exact function of PINK1 in mitochondria has not been investigated
using cells with null expression of PINK1. Here, we show that loss of
PINK1 causedmitochondrial dysfunction. In PINK1-deﬁcient (PINK1−/−)
mouse embryonicﬁbroblasts (MEFs),mitochondrialmembrane potential
and cellular ATP levelswere decreased comparedwith those in littermate
wild-type MEFs. However, mitochondrial proton leak, which reduces
membrane potential in the absence of ATP synthesis, was not altered by
loss of PINK1. Instead, activity of the respiratory chain, which produces
the membrane potential by oxidizing substrates using oxygen, declined.
H2O2 production rate by PINK1−/− mitochondria was lower than
PINK1+/+ mitochondria as a consequence of decreased oxygen
consumption rate, while the proportion (H2O2 production rate per
oxygen consumption rate) was higher. These results suggest that
mitochondrial dysfunctions in PD pathogenesis are caused not by
proton leak, but by respiratory chain defects.
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The selective loss of neural cells from a particular brain region is a
common feature of neurodegenerative diseases. A failure of mito-
chondrial function seems to be a causative factor. Hypoxia [1,2] and
toxins, such as 3-nitropropionic acid (3-NPA, [3–5]) and 1-methyl-4-
phenylpyridinium (MPP+ [6,7]), affect mitochondrial function as well
as neural cell viability and are known as inducers of stroke,
Huntington's and Parkinson's disease, respectively.
We demonstrated that hypoxia and these neurotoxins affect
mitochondrial gene expression, ATP and reactive oxygen species
(ROS) production and that cytochrome c oxidase (COX), the terminal
enzyme of the mitochondrial respiratory chain, appears to play a
crucial role. The application of hypoxia [1,2], 3-NPA [3–5] and MPP+
[6,7] to cultured primary astrocytes and neurons from different brain
regions of female and male mice caused an increase of COX isoform
IV-2 transcription and protein expression in neural cells from cortex
(hypoxia), female/male striatum (3-NPA) andmalemidbrain (MPP+).
A siRNA against COX IV-2 revealed that COX IV-2 is causally related
to elevated intracellular ATP levels at the expense of increased mito-
chondrial ROS production and neural cell death.
Our data suggest that cell death in response to hypoxia, 3-NPA and
MPP+ is primarily caused due to increased oxidative stress in neural
cells in a brain region-speciﬁc and in case of MPP+ also in a gender-
speciﬁc way. COX appears to take center stage of metabolic and cell
survival control in stroke and neurodegeneration [8].
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